drugset / Trial / NCT05340010

Administration of Human Chorionic Gonadotrophin Before Secretory Transformation of Frozen-thawed Embryo Transfer Cycles

NCT05340010

Phase 4 Completed 180 enrolled Alexandria University
RandomizedParallel-groupOpen-labelTreatment

Summary

Successful embryo implantation is complicated process that requires synchrony between good-quality embryos and receptive endometrium. Human chorionic gonadotropin (hCG), is one of the initial embryonic signals and the major embryoendometrial relationship regulator. This study will be conducted to to investigate the role of parenteral hCG used for the transfer of cryopreserved- thawed embryos with HRT cycles in the outcome of artificially prepared frozen embryo transfer (FET) cycles.

Timeline

Start
2020-01-01
Primary completion
2022-06-20
Completion
2022-07-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject human chorionic gonadotropin Protein / enzyme biologic 10000 iu Intramuscular

Indications

No indication recorded.